Approval · Notice of Compliance 10129 · 2009
EMEND IV: Notice of Compliance 10129
Issued April 1, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10129
- Date
- April 1, 2009
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Neurokinin 1 (nk1) receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMEND IV | 02324679 | Cancelled Post Market |
Medicinal ingredients
- FOSAPREPITANT DIMEGLUMINE 115 MG per VIAL